Clinical trial
Post-market Clinical Follow-up Study Evaluating the Efficacy and Safety of LifeVest in Real-life Settings in France
NCT03319160 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-market Clinical Follow-up Study Evaluating the Efficacy and Safety of LifeVest in Real-life Settings in France
- Lead sponsor
- Zoll Medical Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 2, 2017
- Completion date
- March 30, 2019
- Enrollment
- 1,164 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac arrythmias, cardiac event, left ventricular dysfunction, sudden cardiac death